Anti-Human CD52 Immunoglobulins
Copyright © Targeted News Service 2024
2024-04-02
ALEXANDRIA, Virginia, April 2 -- GENZYME CORPORATION, Cambridge, Massachusetts has been assigned a patent (No. US 11945874 B2, initially filed March 3, 2021) developed by four inventors Bruce L. Roberts, Southborough, Massachusetts; Srinivas Shankara, Shrewsbury, Massachusetts; William Harold Brondyk, Mansfield, Massachusetts; and William M. Siders, Franklin, Massachusetts, for "Anti-human CD52 immunoglobulins." . . .